Form 4 for GH Guardant Health, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001702824-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-17 | 2026-03-15 | GH | Bell Michael Brian | CFO | F - Tax | $85.49 | -7,413 | 46.6K | -14% | -$633.7K |
| DM | 2026-03-17 | 2026-03-15 | GH | Bell Michael Brian | CFO | M - OptEx | $0.00 | +13.8K | 41.5K | +50% | $0 |
| D | 2026-03-17 | 2026-03-16 | GH | Bell Michael Brian | CFO | S - Sale+OE | $87.04 | -3,000 | 43.6K | -6% | -$261.1K |
| DM | 2026-03-17 | 2026-03-15 | GH | Bell Michael Brian | CFO | M - OptEx | $0.00 | -13.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | F | D | 7,413 | $85.49 | 46,601 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 2 | Common | Common Stock | 2026-03-15 | M | A | 2,039 | $0.00 | 54,014 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-15 | M | A | 10,518 | $0.00 | 51,975 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-15 | M | A | 1,233 | $0.00 | 41,457 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-16 | S | D | 3,000 | $87.04 | 43,601 | D | — | — | (F2) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $87.0001 to $87.1500. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 6 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 2,039 | $0.00 | 2,039 | D | $0.00 · — to — | 2,039 Common Stock | (F6) This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. (F4) Not applicable for Restricted Stock Units. |
| 7 | Derivative | Performance-Based Restricted Stock Units | 2026-03-15 | M | D | 10,518 | $0.00 | 0 | D | $0.00 · — to — | 10,518 Common Stock | (F5) This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. (F4) Not applicable for Restricted Stock Units. |
| 8 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 1,233 | $0.00 | 0 | D | $0.00 · — to — | 1,233 Common Stock | (F3) This represents a restricted stock unit award granted on May 9, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on March 15, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. (F4) Not applicable for Restricted Stock Units. |